We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
(+43%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$139M |
| 2 |
Procter & Gamble
PG
|
+$118M |
| 3 |
Teleflex
TFX
|
+$90.1M |
| 4 |
Microsoft
MSFT
|
+$89.4M |
| 5 |
UBS Group
UBS
|
+$77.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$203M |
| 2 |
AGN
Allergan plc
AGN
|
+$177M |
| 3 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$118M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
Linde
LIN
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.29% |
| 2 | Consumer Discretionary | 15.87% |
| 3 | Technology | 12.26% |
| 4 | Financials | 12.01% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
NCR Voyix
VYX
$1.06B
| $1.06M | 0.01% |
99,764
-467,140
| -82% | -$5.35M |
|
977
Provident Financial Services
PFS
$3.11B
| $1.06M | 0.01% |
+73,039
| New | +$976K |
|
978
TIM SA
TIMB
$10.2B
| $1.05M | 0.01% |
+81,264
| New | +$1.01M |
|
979
TAL Education Group
TAL
$5.71B
| $1.05M | 0.01% |
15,338
-164,591
| -91% | -$9.41M |
|
980
Xenon Pharmaceuticals
XENE
$6.32B
| $1.04M | 0.01% |
+82,912
| New | +$1.06M |
|
981
Manulife Financial
MFC
$72.6B
| $1.04M | 0.01% |
77,800
+64,200
| +472% | +$808K |
|
982
PLDT
PHI
$4.25B
| $1.04M | 0.01% |
42,464
-57,565
| -58% | -$1.37M |
|
|
CCRD
983
DELISTED
CoreCard
CCRD
| $1.03M | 0.01% |
30,376
-4,969
| -14% | -$166K |
|
|
NXGN
984
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.03M | 0.01% |
93,870
-17,712
| -16% | -$184K |
|
985
Saratoga Investment
SAR
$309M
| $1.03M | 0.01% |
64,977
-9,093
| -12% | -$134K |
|
986
Marvell Technology
MRVL
$174B
| $1.01M | 0.01% |
28,829
+27,151
| +1,618% | +$795K |
|
987
Fulton Financial
FULT
$4.7B
| $1.01M | 0.01% |
+95,868
| New | +$1.04M |
|
|
BEAT
988
DELISTED
BioTelemetry, Inc.
BEAT
| $1.01M | 0.01% |
+22,339
| New | +$1M |
|
989
StoneCo
STNE
$2.62B
| $1.01M | 0.01% |
+25,951
| New | +$757K |
|
|
CTEV
990
Claritev Corp
CTEV
$368M
| $1M | 0.01% |
+2,318
| New | +$935K |
|
991
Robert Half
RHI
$3.61B
| $991K | 0.01% |
18,767
+18,457
| +5,954% | +$876K |
|
|
CIIC
992
DELISTED
CIIG Merger Corp. - Class A Common Stock
CIIC
| $990K | 0.01% |
100,000
| – | – |
|
|
OSB
993
DELISTED
Norbord Inc.
OSB
| $985K | 0.01% |
+43,285
| New | +$744K |
|
994
Raymond James Financial
RJF
$32.5B
| $983K | 0.01% |
21,426
-115,394
| -84% | -$5.2M |
|
995
Expedia Group
EXPE
$31.2B
| $982K | 0.01% |
11,943
-40,634
| -77% | -$2.95M |
|
996
NETSCOUT
NTCT
$2.86B
| $981K | 0.01% |
+38,393
| New | +$992K |
|
997
Rayonier
RYN
$6.49B
| $981K | 0.01% |
+43,615
| New | +$949K |
|
998
Qfin Holdings
QFIN
$1.61B
| $978K | 0.01% |
+91,248
| New | +$831K |
|
999
Tandem Diabetes Care
TNDM
$1.17B
| $978K | 0.01% |
+9,890
| New | +$789K |
|
|
GOGL
1000
DELISTED
Golden Ocean Group
GOGL
| $976K | 0.01% |
252,746
+62,590
| +33% | +$220K |
|
Similar funds
Marshall Wace's Q2 2020 Portfolio in Review
As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.
- Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
- Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
- Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
- Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
- Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
- Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
- Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.
Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.